Larvol Delta - Anixa-Biosciences-Receives-Notice-of-Allowance-from-Canadian-Intellectual-Property-Ofce-for-Patent-Covering-Breast-Cancer-Vaccine-Technology

alpha-lactalbumin vaccine - Anixa Biosci, Cleveland Clinic

https://www.prnewswire.com/news-releases/anixa-biosciences-receives-notice-of-allowance-from-canadian-intellectual-property-office-for-patent-covering-breast-cancer-vaccine-technology-302516540.html

Jul 30, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next